← Back to search

IRONWOOD PHARMACEUTICALS, INC.

IRWD · NASDAQ

Pharmaceutical Preparation Manufacturing

Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

ESG Scores

Overall ESG
4.3
Environmental
4.6
Social
3.0
Governance
6.6

Gender Diversity

Female Directors0.3333%
Female Executives0.23076923076923078%
Women in Workforce0.521%
CEO GenderMale

Market Data

Price$3.41+0.17 (+5.25%)
Market Cap$567M
P/E Ratio5.55
EPS$—
52W High$5.78
52W Low$0.56
Beta0.25